SGHTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Sight Sciences, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$8.26−0.02 (-0.24%)
Close on Oct 19, 2026
- Market cap
- $450.22M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$3.57 (+76.12%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Sight Sciences, Inc. grew revenue 9.3% to $83.38M over the twelve months to Jun 30, 2026. Free cash flow was -$23.33M.
Revenue
$83.38M
+9.3% vs. a year earlier
Operating income
-$27.88M
TTM Q2 2026
Free cash flow
-$23.33M
TTM Q2 2026
EPS, diluted
-$0.56
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $450.22M
- P/E ratio
- –
- Price to sales
- 5.40
- Price to book
- 8.51
- Dividend yield
- –
- Free cash flow yield
- -5.18%
Fundamentals
- Revenue
- $83.38M
- Net income
- -$29.76M
- EPS, diluted
- -$0.56
- Free cash flow
- -$23.33M
- Book value per share
- $0.97
- Diluted shares
- 55M
Seven years at a glance
Fiscal years 2019 to 2025 and trailing twelve months, USD
Revenue
$83.38M+9.3% YoY
Gross profit
$73.34M+12.6% YoY
Operating income
-$27.88M
Net income
-$29.76M
EPS, diluted
-$0.56
Free cash flow
-$23.33M
Reported periodTrailing twelve months